MATTHEW W. FOEHR - Director at Viking Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
VKTX on Nasdaq
All Insider Reports
All Insider Reports

MATTHEW W. FOEHR - trading volume in the past year for Viking Therapeutics, Inc.

Holdings reported by MATTHEW W. FOEHR for Viking Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.00001 per share 135,186 $5,030,271 $37.21 02 Jan 2026 Direct
Stock Option (Right to Buy) 20,400 02 Jan 2026 Direct Common Stock

Transactions reported by MATTHEW W. FOEHR for Viking Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.